↓ Skip to main content

Effect of Melissa officinalis (Lemon balm) on Sexual Dysfunction in Women: A Double- blind, Randomized, Placebo-controlled Study.

Overview of attention for article published in Iranian Journal of Pharmaceutical Research, January 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of Melissa officinalis (Lemon balm) on Sexual Dysfunction in Women: A Double- blind, Randomized, Placebo-controlled Study.
Published in
Iranian Journal of Pharmaceutical Research, January 2018
Pubmed ID
Authors

Darvish-Mofrad-Kashani, Zahra, Emaratkar, Elham, Hashem-Dabaghian, Fataneh, Emadi, Fatemeh, Raisi, Firoozeh, Aliasl, Jale, Kamalinejad, Mohammad, Hasheminejad, Seyed Abbas, Eftekhar, Tahere, Zafarghandi, Nafise, Zahra Darvish-Mofrad-Kashani, Elham Emaratkar, Fataneh Hashem-Dabaghian, Fatemeh Emadi, Firoozeh Raisi, Jale Aliasl, Mohammad Kamalinejad, Seyed Abbas Hasheminejad, Tahere Eftekhar, Nafise Zafarghandi

Abstract

Hypoactive sexual desire disorder (HSDD) is the most prevalent female sexual dysfunction (FSD) and its bio-psychosocial multifactorial etiology justifies its multifaceted treatment. In Persian Medicine (PM), the weakness of the main organs (heart, brain and liver) is one of the important causes of lack of sexual desire; hence, their strengthening is a priority during treatment. Melissa officinalis is one of the medicinal plants with tonic characteristics for the main organs in PM and was used for treatment in this study. The aim of the present study was to evaluate the efficacy and safety of M. officinalis in the improvement of HSDD in women. Eighty nine (89) eligible women suffering from decreased sexual desire were randomly assigned to groups. The participants received medication (500 mg of aqueous extract of M. officinalis) or placebo 2 times a day for 4 weeks. Changes in scores of desire, arousal, lubrication, orgasm, satisfaction and pain were evaluated at the end of 4 weeks of treatment using the Female Sexual Function Index (FSFI) questionnaire in the two groups. Forty three participants completed the study. The increase in desire (P < 0.001), arousal (P < 0.001), lubrication (P < 0.005), orgasm (P < 0.001), satisfaction (P < 0.001), pain (P < 0.002) and FSFI total score (P < 0.001) in the M. officinalis group was significantly more than that of the placebo group. The willingness to continue treatment was significantly higher in the M. officinalis as compared to the placebo group (P < 0.001). M. officinalis may be a safe and effective herbal medicine for the improvement of HSDD in women.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 21%
Student > Doctoral Student 4 14%
Other 4 14%
Researcher 2 7%
Student > Bachelor 2 7%
Other 4 14%
Unknown 6 21%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 18%
Agricultural and Biological Sciences 4 14%
Medicine and Dentistry 4 14%
Biochemistry, Genetics and Molecular Biology 2 7%
Psychology 2 7%
Other 5 18%
Unknown 6 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2019.
All research outputs
#9,328,081
of 16,218,785 outputs
Outputs from Iranian Journal of Pharmaceutical Research
#89
of 267 outputs
Outputs of similar age
#141,425
of 282,023 outputs
Outputs of similar age from Iranian Journal of Pharmaceutical Research
#1
of 1 outputs
Altmetric has tracked 16,218,785 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 267 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,023 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them